Personalized cancer vaccine responders are alive six years on

Claim

Personalized mRNA vaccines for pancreatic cancer are showing durable results, with trial responders still alive six years later against a thirteen percent five-year survival baseline.

Reported metric: 6 years vs 13% at 5

Reporting date: 2026-04-20 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

• Welcome to April 20, 2026 (theinnermostloop.substack.com)